Expedited Review claims are paid the current Payment Percentage of the Scheduled Value for each disease as outlined in the TDP. Expedited Review is also intended to provide qualifying claimants a fixed and certain claim payment.  The current Payment Percentage is 60%.

Halliburton or Non-Harbison-Walker Entity Claims

Disease LevelScheduled Value
Mesothelioma  (Level VIII)
$60,117.77
Lung Cancer 1 (Level VII)
$9,774.39
Other Cancer  (Level V)
$8,408.08
Severe Asbestosis  (Level IV)
$9,879.49
Asbestosis/Pleural Disease (Level III)
$2,522.42
Asbestosis/Pleural Disease (Level II)
$1,156.11
Other Asbestos Disease (Level I)
$105.10

 

Harbison-Walker Entity Claims

Disease LevelScheduled Value
Mesothelioma (Level VIII)
$143,462.87
Lung Cancer 1 (Level VII)
$47,190.35
Other Cancer (Level V)
$25,224.24
Severe Asbestosis (Level IV)
$31,004.80
Asbestosis/Pleural Disease (Level III)
$7,567.27
Asbestosis/Pleural Disease (Level II)
$3,993.84
Other Asbestos Disease (Level I)
$315.30